Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | follicle stimulating hormone receptor | Get druggable targets OG5_130089 | All targets in OG5_130089 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | Get druggable targets OG5_130089 | All targets in OG5_130089 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0154 | 0.1876 | 0.1846 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 0.5 |
Loa Loa (eye worm) | HMG box family protein | 0.0064 | 0.0594 | 0.1173 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0042 | 0.0286 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0021 | 0 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0042 | 0.0286 | 0.5 |
Echinococcus granulosus | pangolin | 0.0064 | 0.0594 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0143 | 0.0022 |
Echinococcus multilocularis | T cell transcription factor 4 long C terminal | 0.0064 | 0.0594 | 0.0487 |
Leishmania major | DNA polymerase kappa, putative | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0154 | 0.1876 | 0.4445 |
Onchocerca volvulus | Cirhin homolog | 0.0094 | 0.1029 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0154 | 0.1876 | 0.4445 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0042 | 0.0286 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Trypanosoma brucei | unspecified product | 0.0035 | 0.0192 | 0.67 |
Echinococcus granulosus | T cell transcription factor 4 long C terminal | 0.0064 | 0.0594 | 0.0466 |
Brugia malayi | Armadillo/beta-catenin-like repeat family protein | 0.0095 | 0.1038 | 0.2307 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0042 | 0.0286 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0042 | 0.0286 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0042 | 0.0286 | 0.0153 |
Echinococcus multilocularis | dna polymerase kappa | 0.0042 | 0.0286 | 0.016 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0154 | 0.1876 | 0.1765 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 0.5 |
Brugia malayi | HMG box family protein | 0.0064 | 0.0594 | 0.1173 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0032 | 0.0143 | 0.5008 |
Echinococcus multilocularis | beta catenin | 0.0095 | 0.1038 | 0.0958 |
Schistosoma mansoni | beta-catenin | 0.0095 | 0.1038 | 0.3199 |
Echinococcus multilocularis | protein pangolin J | 0.0064 | 0.0594 | 0.0487 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0309 | 0.4051 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Brugia malayi | polk-prov protein | 0.0032 | 0.0143 | 0.0022 |
Echinococcus multilocularis | conserved hypothetical protein | 0.07 | 0.9564 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0154 | 0.1876 | 0.1846 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0042 | 0.0286 | 0.5 |
Echinococcus granulosus | beta catenin | 0.0095 | 0.1038 | 0.0916 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0032 | 0.0143 | 0.5008 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0035 | 0.0192 | 0.67 |
Schistosoma mansoni | pangolin | 0.0064 | 0.0594 | 0.1626 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0154 | 0.1876 | 0.6163 |
Brugia malayi | follicle stimulating hormone receptor | 0.0309 | 0.4051 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0231 | 0.2959 | 1 |
Loa Loa (eye worm) | HMP-2 protein | 0.0095 | 0.1038 | 0.2307 |
Echinococcus granulosus | hypothetical protein | 0.0294 | 0.3846 | 0.3762 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0042 | 0.0286 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 84.9214 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.